LARTRUVO

eli lilly canada inc🇨🇦 Health Canada

Approval Id: 185fd9281ee20906
Drug Approval Canada Name: LARTRUVO
Product Name: LARTRUVO
Status: Cancelled Post Market
Status Date: 2020-09-25
Original Market Date: 2020-06-09
Din: 02480271
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FX10 OLARATUMAB
Atc Name: l 01 fx 10
Aig Number: 0159610001
Company Name: eli lilly canada inc
Company Address: SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1

OLARATUMAB

190 MG / 19 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

185fd9281ee20906

Type

Standard